Abbott (ABT) Dips More Than Broader Markets: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Abbott (ABT) closed the most recent trading day at $81.90, moving -1% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.16%. Elsewhere, the Dow lost 0.12%, while the tech-heavy Nasdaq lost 0.33%.

Heading into today, shares of the maker of infant formula, medical devices and drugs had gained 7.41% over the past month, outpacing the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

ABT will be looking to display strength as it nears its next earnings release, which is expected to be April 16, 2020. The company is expected to report EPS of $0.62, down 1.59% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $7.64 billion, up 1.4% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $3.26 per share and revenue of $32.17 billion, which would represent changes of +0.62% and +0.84%, respectively, from the prior year.

It is also important to note the recent changes to analyst estimates for ABT. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 9.39% lower. ABT is holding a Zacks Rank of #4 (Sell) right now.

Looking at its valuation, ABT is holding a Forward P/E ratio of 25.38. Its industry sports an average Forward P/E of 24.63, so we one might conclude that ABT is trading at a premium comparatively.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

The Rise of Sabre Corporation

The Sabre Corporation is an international corporation founded in 1983 by two college roommates in Tampa, Florida. They had a unique idea for a...

Mesothelioma – The Hidden Cancer

Mesothelioma is a rare form of cancer that mainly affects the chest and abdomen areas. It usually starts in the mesothelium, which is the...

Nightmare scenario for economy is becoming less likely, award-winning forecaster says

Even in normal times, being an economic forecaster requires a multi-disciplinary approach. Not only do you need to understand the economic relationships, but you...

Asian shares mostly higher following Wall Street gains

Shares were mostly higher in Asia on Tuesday, lifted by moves to reopen many regional economies from shutdowns aimed at containing the coronavirus pandemic. Benchmarks...

Business Casual Clothing Is the New Dress Code

Business Casual Clothing Is the New Dress CodeYou've probably heard a lot about business casual clothing. You may have seen a dress code...
Home of Science
Follow me